Principal Securities Inc. Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Principal Securities Inc. lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,632 shares of the medical equipment provider’s stock after selling 158 shares during the period. Principal Securities Inc.’s holdings in Intuitive Surgical were worth $3,984,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.7 %

Shares of ISRG opened at $595.55 on Monday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a fifty day simple moving average of $559.48 and a two-hundred day simple moving average of $519.66. The company has a market capitalization of $212.12 billion, a PE ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39.

Analyst Ratings Changes

A number of research analysts have issued reports on ISRG shares. Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank raised their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, BTIG Research raised their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock valued at $3,587,582 over the last ninety days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.